Search Results for "Anxiety"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Anxiety. Results 1 to 10 of 128 total matches.
Drugs for Anxiety Disorders
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023 (Issue 1682)
Drugs for Anxiety Disorders ...
Anxiety disorders (generalized anxiety disorder,
panic disorder, social anxiety disorder, and various
phobias) are the most common form of psychiatric
illness. They can be treated effectively with cognitive
behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8 doi:10.58347/tml.2023.1682a | Show Introduction Hide Introduction
Drugs That May Cause Psychiatric Symptoms
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008 (Issue 1301)
, or psychosocial
factors. The withdrawal of some drugs can cause
symptoms such as anxiety, psychosis, delirium ...
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.
Click here to view the free full article.
Click here to view the free full article.
Alprazolam (Xanax, and others) Revisited
The Medical Letter on Drugs and Therapeutics • Jan 17, 2005 (Issue 1200)
of anxiety and panic disorder. An
extended-release formulation, Xanax XR, which can be
taken once a day ...
Alprazolam, a short-acting benzodiazepine, is one of the most widely prescribed drugs in the US. It is approved by the FDA for treatment of anxiety and panic disorder. An extended-release formulation, Xanax XR, which can be taken once a day, recently became available for panic disorder.
Addendum: Depression and Suicidality with Isotretinoin
The Medical Letter on Drugs and Therapeutics • Aug 01, 2016 (Issue 1500)
has not
been established, however, and acne itself is associated
with symptoms of anxiety and depression.
Two large ...
Our article earlier this year on Drugs for Acne1 stated that the oral retinoid isotretinoin (Accutane, and others) is the most effective drug available for patients with severe nodulocystic acne, but warned that depression, suicidality, myalgia, hypertriglyceridemia, and other adverse effects can occur. One of our readers objected to our listing depression and suicidality, which are the subject of a prominent warning in the package insert, in the same sentence as indisputable side effects such as hyperlipidemia and myalgia.Depression and suicidal ideation have been reported in patients with...
Extended-Release Fluvoxamine (Luvox CR)
The Medical Letter on Drugs and Therapeutics • Jun 30, 2008 (Issue 1289)
of OCD and
social anxiety disorder (SAD) in adults.
PHARMACOKINETICS — According to data ...
Fluvoxamine maleate, a selective serotonin reuptake inhibitor (SSRI) that has been available for many years in an immediate-release formulation (Luvox, and others) for treatment of obsessive-compulsive disorder (OCD) in children and adults, has now been approved by the FDA in an extended-release formulation (Luvox CR - Jazz Pharmaceuticals) for treatment of OCD and social anxiety disorder (SAD) in adults.
Ashwagandha Supplements
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
as winter cherry
and Indian ginseng, are widely promoted now in the
US for treatment of pain, anxiety ...
Ashwagandha is an herb extracted from the roots of
an evergreen shrub (Withania somnifera) found in
India that has been used as a "tonic" for centuries.
No specific constituent has been identified as an
active ingredient. Herbal supplements containing
ashwagandha, which is also known as winter cherry
and Indian ginseng, are widely promoted now in the
US for treatment of pain, anxiety, stress, fatigue, sleep
disturbances, cognitive decline, diabetes, arthritis,
male infertility, and various cancers.
Xanax XR for Panic Disorder
The Medical Letter on Drugs and Therapeutics • May 26, 2003 (Issue 1157)
dosing and problems of interdose anxiety.
TREATMENTS FOR PANIC DISORDER — Benzodiazepines can provide ...
The FDA has approved an extended-release (XR) formulation of the benzodiazepine alprazolam (Xanax XR - Pfizer) for treatment of panic disorder, with or without agoraphobia. The new formulation is intended to reduce the need for frequent dosing and problems of interdose anxiety. This review describes the effectiveness of the extended-release formulation, as well as sections on dependence, abuse and withdrawal, adverse effects, and drug interactions. The review concludes with an overall assessment of the drug's efficacy and cost.
Choice of Benzodiazepines
The Medical Letter on Drugs and Therapeutics • Feb 26, 1988 (Issue 760)
are
effective for treatment of anxiety and insomnia. Although flurazepam, temazepam, and triazolam
are most ...
Since The Medical Letter last reviewed the choice of benzodiazepines (Volume 23, page 41, 1981), several new drugs have been marketed and some old ones are now available generically. Most of the benzodiazepines available for oral use in the USA are listed in the table on page 28.
Alprazolam For Panic Disorder
The Medical Letter on Drugs and Therapeutics • Apr 05, 1991 (Issue 841)
previously available in the USA for
treatment of anxiety (Medical Letter 24:41, 1982), was recently approved ...
Alprazolam (Xanax - Upjohn), a triazolobenzodiazepine previously available in the USA for treatment of anxiety (Medical Letter 24:41, 1982), was recently approved by the US Food and Drug Administration (FDA) for treatment of panic disorder, with or without agoraphobia. According to one report, alprazolam was the fifth most widely prescribed drug in the USA last year (American Medical News, March 4, 1991, page 4).
In Brief: Respiratory Depression with Gabapentinoids
The Medical Letter on Drugs and Therapeutics • Jun 01, 2020 (Issue 1599)
-neuropathic pain,
anxiety, and insomnia, and hot flashes in women with breast
cancer.2-5 Often prescribed ...
The FDA has required new warnings in the labels of
gabapentin (Neurontin, and others) and pregabalin (Lyrica,
Lyrica CR, and generics) about the risk of life-threatening or
fatal respiratory depression in patients with respiratory risk
factors. Respiratory risk factors include chronic obstructive
pulmonary disease (COPD) and concurrent use of opioids
or other CNS depressants. Elderly patients are also at
increased risk.